Relay Therapeutics, Inc. ($RLAY)
Filing Information
| Accession Number | 0001193125-26-281061 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
526,055
Total Value
$4,011,533.57
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Sale | 17,717 | $17.01 | $301,366.17 | 177,461 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Exercise/Conversion | 56,323 | $5.04 | $283,867.92 | 233,784 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Sale | 56,323 | $16.97 | $955,801.31 | 177,461 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Exercise/Conversion | 61,563 | $5.22 | $321,358.86 | 239,024 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Sale | 61,563 | $16.97 | $1,044,724.11 | 177,461 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Exercise/Conversion | 51,560 | $4.45 | $229,442.00 | 229,021 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Sale | 51,560 | $16.97 | $874,973.20 | 177,461 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 56,323 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 61,563 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 51,560 | $0.00 | $0.00 | 223,440 | Direct | โ | View Details |